You are viewing an incomplete version of our website. Please click to reload the website as full version.

Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 29-44) antibody

Details for Product No. ABIN123477, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

AA 29-44
(10), (5), (4), (4), (3), (3), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Human, Mouse (Murine)
(46), (30), (14)
(42), (9), (4), (3)
(2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Western Blotting (WB)
(36), (20), (11), (10), (7), (4)
Pubmed 2 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.1 mg
Shipping to United States ( )
Immunogen Mixture of synthetic peptides corresponding to amino acids 29-44, 204-219, and 409-421 of human TROY
Purification Protein G Chromatography
Alternative Name TNFRSF19 / TRADE (TNFRSF19 Antibody Abstract)
Background Analysis of EST clones and use of a signal sequence trap screening of the murine brain have lead to identification of a new member of the tumor necrosis factor receptor superfamily designated as TAJ and TROY, respectively (2,3). TAJ/TROY is a membrane protein of 423 amino acids with characteristic cysteine-rich motifs in the extracellular domain and a tumor necrosis factor receptor-associated factor (TRAF) 2 binding sequence in the cytoplasmic domain. Human TROY has 78% identity at the amino acid level with mouse TROY. The extracellular domain of TROY has significant homology with that of EDAR (another newly identified receptor belonging to TNF receptor family) that specifies hair follicle fate (1). The cytoplasmic domain of TAJ is different than other TNF receptor family members. Although its cytoplasmic domain does not contain death domain, TAJ/TROY induced cell death is probably mediated through a caspase- independent pathway. TAJ-induced JNK activation was not blocked by dominant-negative inhibitors of TRAF2, TRAF5, or ASK1, which have been previously implicated in JNK activation via TNFR1 and CD40. However, coimmunoprecipitation assays revealed that TAJ is capable of binding a number of different TRAF family members, and it is possible that TAJ-induced JNKactivation is mediated by an as yet untested TRAF homolog, such as TRAF6. TROY mRNA is highly expressed in brain, prostate and embryo and moderately expressed in the heart, lung, liver.
UniProt Q9NS68
Application Notes Western blot: 0.5 - 2.0 ug/ml. Recommended positive control: T98G. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS containing 0.02% sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Store the antibody at 2 - 8 °C up to six months or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch.
Expiry Date 12 months
Supplier Images
Western Blotting (WB) image for anti-Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19) (AA 29-44) antibody (ABIN123477) Western blot analysis of TAJ/TROY using ABIN123477 in T98G, a human glioblastoma cell...
General Kojima, Morikawa, Copeland et al.: "TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles." in: The Journal of biological chemistry, Vol. 275, Issue 27, pp. 20742-7, 2000 (PubMed).

Monreal, Ferguson, Headon et al.: "Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia." in: Nature genetics, Vol. 22, Issue 4, pp. 366-9, 1999 (PubMed).

Catalog No. ABIN123477

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)
Did you look for something else?